HIV infection and the intestinal mucosal barrier
- PMID: 22731711
- DOI: 10.1111/j.1749-6632.2012.06512.x
HIV infection and the intestinal mucosal barrier
Abstract
HIV infection induces a barrier defect of the intestinal mucosa, which is closely linked to immune activation and CD4 T cell depletion. The HIV-induced barrier defect is initiated in early acute and maintained through chronic infection. In acute infection, increased epithelial permeability is associated with increased epithelial apoptosis possibly caused by perforin-expressing cytotoxic T cells. In chronic infection, mucosal production of inflammatory cytokines is associated with increased epithelial permeability, epithelial apoptosis, and alterations of epithelial tight junctions. In addition to HIV-induced immune-mediated effects, viral proteins have the potential to directly affect epithelial barrier function. After prolonged viral suppression by antiretroviral therapy, there is, at least partial, restoration of the HIV-associated intestinal mucosal barrier defect despite persisting alterations of the mucosal immune system.
© 2012 New York Academy of Sciences.
Similar articles
-
Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect.Gastroenterology. 2010 Oct;139(4):1289-300. doi: 10.1053/j.gastro.2010.06.065. Epub 2010 Jun 27. Gastroenterology. 2010. PMID: 20600014
-
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.Gut. 2009 Feb;58(2):220-7. doi: 10.1136/gut.2008.150425. Epub 2008 Oct 20. Gut. 2009. PMID: 18936106
-
Th17 cells, HIV and the gut mucosal barrier.Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Curr Opin HIV AIDS. 2010. PMID: 20543596 Review.
-
Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy.J Infect Dis. 1999 May;179 Suppl 3:S454-6. doi: 10.1086/314803. J Infect Dis. 1999. PMID: 10099118 Review.
-
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.Antivir Ther. 2009;14(3):321-30. Antivir Ther. 2009. PMID: 19474466
Cited by
-
Amino Acid Concentrations in HIV-Infected Youth Compared to Healthy Controls and Associations with CD4 Counts and Inflammation.AIDS Res Hum Retroviruses. 2017 Jul;33(7):681-689. doi: 10.1089/AID.2015.0369. Epub 2017 Feb 27. AIDS Res Hum Retroviruses. 2017. PMID: 28117597 Free PMC article.
-
Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.Tissue Barriers. 2015 Apr 3;3(1-2):e977176. doi: 10.4161/21688370.2014.977176. eCollection 2015. Tissue Barriers. 2015. PMID: 25838982 Free PMC article.
-
Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease.Front Pharmacol. 2022 Jul 7;13:892790. doi: 10.3389/fphar.2022.892790. eCollection 2022. Front Pharmacol. 2022. PMID: 35873579 Free PMC article. Review.
-
Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.Retrovirology. 2016 Jan 14;13:5. doi: 10.1186/s12977-016-0237-1. Retrovirology. 2016. PMID: 26762145 Free PMC article.
-
Stem Cell-Based Therapies for Inflammatory Bowel Disease.Int J Mol Sci. 2022 Jul 31;23(15):8494. doi: 10.3390/ijms23158494. Int J Mol Sci. 2022. PMID: 35955628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials